Dissertations / Theses on the topic 'Pharmaceutical industry Australia Case studies'

The study analyses the Western Australian mining regulatory framework of environmental compliance. Through the case studies of Yeelirrie uranium mining approval, and Collie coal mining, it identifies a dichotomy (Acts of Parliament and State Agreements) of mining legislation and multi-agency approach challenging effective environmental protection. Grounded in sustainability and social sciences approaches, the thesis draws from expert interviews to identify weaknesses and best practices. It makes recommendations for strengthening the implementation of the mining regulatory framework.

This thesis investigates the contribution to the growth in expenditure on medicines listed on the Pharmaceutical Benefits Scheme (PBS) from three inter-related sources: (i) the addition of new medicines offering an expanding range of treatments for disease, (ii) PBS processes for determining the prices of medicines and their conditions of listing and (iii) the demand by patients for PBS medicines. In doing so it uses trend analysis presented in both tabular and graphic form, expenditure decomposition techniques based on index and indicator numbers, and econometric analysis. Using novel techniques and interpretations, it addresses some key aspects of decomposition analysis including the treatment of new and disappearing goods and the potential bias arising from changing market shares among substitutable medicines. The analysis is undertaken for the period from 1991-92 to 2005-06. An important consequence of the cost-effectiveness and reference pricing techniques used by the PBS, is that the quantity index calculated within the decomposition of PBS expenditure can be interpreted as a measure of the quality-adjusted amount of medicines consumed by patients. This is virtually equivalent to the growth in expenditure of about 12% per annum. On average prices of medicines fell over time, modestly in nominal terms and to a greater extent in real terms. Based on the results of econometric analysis, new evidence is presented on the relative influences of copayments, safety net limits, the number of PBS medicines listed and their conditions of listing on the demand for PBS medicines by different categories of patients. Elasticities with respect to patient price are in the range -1.1 to -1.4 for General Non-Safety Net patients and in the range -0.5 to -0.9 for Concessional Non-Safety Net patients.

Aim: To gather, analyse and present the views of personnel currently working within pharmaceutical companies relating to factors influencing drug diffusion (market penetration), using case studies to determine how their perspective relates to diffusion curves and literature-based timelines describing the same phenomenon. Methods: Qualitative study based on semi-structured interviews with marketing, market access or senior management personnel from eight major UK R&D pharmaceutical companies. Case studies were selected through expert consultation. Diffusion curves were produced for all potential case study drugs (n=21) and timelines constructed from the literature and augmented with clinical expert input. Results: Thematic analysis of 15 interviews conducted across four case studies: bisphosphonates; atypical anti psychotics; phosphodiesterase type 5 inhibitors and statins revealed 10 diffusion themes: clinical need; clinician/patient experience; clinical evidence; health service/policy environments; adopter attitudes; communicating relative advantage; market development; opinion leaders; company culture/ heritage and pricing. Triangulation with diffusion curves and literature-based timelines demonstrated a high level of convergence between accounts. Points of divergence revealed unique pharmaceutical industry insights. Conclusion: Eliciting diffusion knowledge from this under-researched stakeholder group largely confirmed issues previously outlined in the literature, but importantly has revealed the significance of less tangible social interactions that inform perceptions of new pharmaceuticals that can significantly influence adoption and diffusion.

This thesis, conceived within a Marxist framework, addresses key conceptual issues in the writing and theorising on industry policy in post second world- war Australia. Broadly, the thesis challenges the way that industry policy on the left of politics (reflected in the social democratic and Keynesian positions) has been constructed as a practical, progressive policy agenda. Specifically, the thesis poses a direct challenge to the primacy of the ‘national’ in interpreting the history of industry policy. The challenge is to the proposition that conflicts between national industry and international finance arose only from the mid 1980s. On the contrary, as will be seen, this is a 1960s issue and any interpretation of the debates and the agendas surrounding industry policy in the 1980s must be predicated on an understanding of how the issue was played out two decades earlier. As was the case in the 1960s, industry policy in the 1980s has been isolated from two key areas of interrogation: the role of the nation state in regulating accumulation and the role of finance in industry policy. In the 1950s and more so in the 1960s and early 1970s there was a reconfiguration of financing internationally but it is one that did not enter into industry policy analysis. The central concern therefore is to simultaneously sketch the historical political economy on industry policy from the 1950s through to the early 1970s in Australia and to analytically and empirically insert the role of finance into that history. In so doing the thesis addresses the economic and social factors that shaped the approach to industry finance in Australia during this critical period. The analysis is supported by a detailed examination of political and industry debates surrounding the proposal for, and institution of, a key national intervention in the form of the Australian Industry Development Corporation (AIDC).

This thesis investigates the contribution to the growth in expenditure on medicines listed on the Pharmaceutical Benefits Scheme (PBS) from three inter-related sources: (i) the addition of new medicines offering an expanding range of treatments for disease, (ii) PBS processes for determining the prices of medicines and their conditions of listing and (iii) the demand by patients for PBS medicines. In doing so it uses trend analysis presented in both tabular and graphic form, expenditure decomposition techniques based on index and indicator numbers, and econometric analysis. Using novel techniques and interpretations, it addresses some key aspects of decomposition analysis including the treatment of new and disappearing goods and the potential bias arising from changing market shares among substitutable medicines. The analysis is undertaken for the period from 1991-92 to 2005-06. An important consequence of the cost-effectiveness and reference pricing techniques used by the PBS, is that the quantity index calculated within the decomposition of PBS expenditure can be interpreted as a measure of the quality-adjusted amount of medicines consumed by patients. This is virtually equivalent to the growth in expenditure of about 12% per annum. On average prices of medicines fell over time, modestly in nominal terms and to a greater extent in real terms. Based on the results of econometric analysis, new evidence is presented on the relative influences of copayments, safety net limits, the number of PBS medicines listed and their conditions of listing on the demand for PBS medicines by different categories of patients. Elasticities with respect to patient price are in the range -1.1 to -1.4 for General Non-Safety Net patients and in the range -0.5 to -0.9 for Concessional Non-Safety Net patients.

The pharmaceutical industry must worry about managing pharmaceutical waste as it poses a health risk to human beings and its presence in the environment can also contribute to loss of biodiversity. Ngwuluka, Ochekpe, and Odumosu (2011: 11259) state that “Pharmaceuticals, though used to treat and manage diseases, are poisons, which justify the growing concerns about their presence in the environment.” Various forms of pharmaceutical waste exist, Ngwuluka et al. (2011) identified the following forms of pharmaceutical waste: Expired dosage forms, non-reworkable formulations, spilled pharmaceuticals, rejected active pharmaceutical ingredients, expired active pharmaceutical ingredients, and wastewater resulting from the water used for process operations during manufacturing and could come from the water used to clean equipment, pipes and floors, and would contain amongst other materials, chemicals and active pharmaceutical ingredients (APIs). A review on the pharmaceutical industry and the progress they have made in environmental management by generating health, safety and environmental programs, preventing pollution, waste minimization, recycling and reusing materials, investing in projects and facilities to ensure environmental sustainability have been established (Berry & Rondinelli, 2000). Dr. Reddy’s Laboratories is an Indian based pharmaceutical company which imports, markets and sells medicines in South Africa. Dr. Reddy’s has plans to set up a manufacturing plant in South Africa. The purpose of this study is to research waste management practices at Dr. Reddy’s plant in India and to draw parallels between India’s and South Africa’s waste legislation. This is to enable Dr. Reddy’s to review all aspects of its waste management systems, in order to revise where necessary and to improve the overall achievement of its waste management objectives in order to become a more sustainable organisation and to meet South African Waste legislation before setting up a plant in South Africa. 3 ii. Objective of the Evaluation Report The purpose of this research is to evaluate and analyse the development and implementation of a waste management system in a pharmaceutical company, specifically Dr. Reddy’s Laboratories. This is primarily to enable the company to review and analyse all aspects of waste management pertaining to pharmaceutical manufacturing and to revise or improve where necessary to ensure adherence to waste regulations as outlined by government. The following research goals have been also been identified:  To identify and describe waste management practices at Dr. Reddy’s Laboratories, on the inherent assumption by the researcher that the company has a successful waste management strategy that would need to be reviewed to identify areas of improvement before expanding manufacturing facilities into South Africa.  To evaluate, assess and compare similarities and/or differences between the identified South African Legislation for Waste Management with those identified during research conducted at Dr. Reddy’s iii. Importance of the Research Conducted Waste Management is important in that it not only removes from the environment, substances that can be harmful to humans and animals but it also enables an organisation to be more sustainable. According to Seadon (2010: i) “Integrated waste management is considered from a systems’ approach, with a particular emphasis on advancing sustainability”. The study will provide guidance to senior management, shop floor managers and employees who work in Dr. Reddy’s manufacturing plants as well as overall employees at Dr. Reddy’s on how to successfully implement a Waste Management programme to enhance sustainability at the organisation and realise the benefits to the organisation of being more sustainable. Weybrecht (2010) identified the following benefits that companies could gain by adopting sustainable waste management practices: reduced costs, resource preservation, keeping up with legislation, enhanced reputation, business differentiation from competitors, and attraction and retention of quality employees, and customer need satisfaction amongst many other benefits. This research needs to address the gap in analysing waste management practices (with more emphasis on waste treatment, waste minimisation, re-use, recycling and disposal), and implementation and understanding of waste management in the pharmaceutical industry as prior research was done mostly in other chemical industries and not to a large scale in the pharmaceutical industry. South African Waste Legislation, Indian Waste Legislation (as Dr. Reddy’s is based in India), as well as International Pharmaceutical Waste Management Guidelines, and International Pharmaceutical Good Manufacturing Practices provide a framework and benchmark of leading pharmaceutical waste management practices that can guide Dr. Reddy’s Laboratories’ leadership into integrating their waste management practices into their plans of setting up a manufacturing plant in South Africa. 5. Research Methodology This is evaluation research in the form of a case study and the data collection method employed is the conduction of a survey through questionnaires. The evaluation research also involves a document analysis of the organisation’s 2011 and 2012 annual reports, Dr. Reddy’s 2010 Sustainability Report as well as literature compiled by the organisation’s Corporate Communications Division. The research would also include review of existing literature on waste management. v. Structure of Dissertation This dissertation consists of three sections. Section 1: The Evaluation Report The section introduces the research area, provides the objectives of the research, provides contextual background information and describes the rationale for conducting the research. This section further describes Dr. Reddy’s waste management practice as outlined in relevant company documentation; it is also intended to highlight the specific waste management processes that were followed in the formulation and implementation of the waste management strategy. This section further describes the sample and presents the results of the survey, where the results are collated and reviewed in the context of the criteria set in the South African Waste Legislation, Indian Waste Legislation, as well as in International Pharmaceutical Waste Management Guidelines, and International Pharmaceutical Good Manufacturing Practices. The overall findings of this case study suggest that although management at Dr. Reddy’s are satisfied with waste management practices and results achieved at it manufacturing plant, there is however dissatisfaction amongst employees who believe the organisation has not successfully disseminated information and sufficiently trained them on waste management policies, processes and practices. There is therefore a desire amongst employees to be trained and to see the company improve on its waste management processes, this desire is a very important attribute as it indicates that employees at Dr. Reddy understand and are committed to the importance of waste management. Future research should be conducted to measure the legal impact of non-compliance to legislation governing waste management in the pharmaceutical company. Section 2: Literature Review The objective of the literature review is to provide a critical assessment and evaluation of previous research in the field of waste management in general as prior research was done mostly in other industries and not to a large scale in the pharmaceutical industry. The literature review evaluates the key elements of an effective waste management strategy implementation and is followed by a review of literature pertaining to the description of Pharmaceutical waste. Section 3: Research Methodology This section presents a description of how the work in this research was conducted. It presents the research process followed in compiling this case study, represented by the aims and objectives, research methodology and design, data collection techniques and data analysis.

The literature about information systems adoption generally, and specifically the use of EOI within supply chains. indicates that there are significant savings to be made, primarily by reductions in inventory costs. The Iiterature surrounding the Efficient Consumer Response (ECR) movement within the retail supply chain also claims that there are significant savings to be made and that these savings will be shared by partners within the supply chain and be passed on to consumers. This is a two stage study of a local case organisation operating within a duopoly industry environment. The research was conductad during the period of 1999 to 2005.

With the growing trend of globalization and rapid development of high technologies, emerging economies face more challenges in technology development because they are chasing a fast-moving frontier. They need to identify global technology trends and adapt to local needs and capabilities. Strategies for technology development differ among countries at different developmental stages. In this research, a technology policy choice framework is developed to link prospective high-tech areas, technology development strategies, and various innovative resources. The research approach is to develop a hierarchical decision model (HDM) and apply the analytic hierarchical process (AHP). Experts are invited from diverse sources to provide a balanced perspective representing different stakeholders. This research focuses on the fast developing Chinese biopharmaceutical industry as a case study. The results of this research have identified thirteen prospective biotech areas that China should invest more resources for development. These technology areas include: recombinant therapeutic proteins, recombinant vaccines, monoclonal antibody technology, cell and tissue engineering, gene therapy, antisense therapy, RNAi, nanobiotechnology, synthetic biology, bioinformatics, pharmacogenetics, gene sequencing, and biotechnology diagnostics. For most of these technology areas, the results have indicated an imitative innovation strategy should be taken as a better strategy under current technological conditions in China. The research has further found that high-tech small-to-medium companies and multinational corporations are major innovation contributors in the Chinese biopharmaceutical sector. The research outcomes can serve as guidelines in resource allocation and policy making for technology development. Based on the overall research findings, policy-makers can apply more specific policy instruments to support innovation activities. Appropriate policy measures may help the country to construct an innovative ecosystem that can serve as the driving force for future technology development.

Doutoramento em Gestão
Os relacionamentos horizontais, como sejam as alianças estratégicas, são cada vez mais importantes e prevalecentes. O propósito desta investigação é a compreensão do desenvolvimento de relacionamentos horizontais, utilizando a perspetiva de interação e redes. Foi desenvolvida investigação de relevo em alianças estratégicas salientando as motivações, antecedentes, formação e resultados. Todavia, os investigadores têm vindo a descurar os processos de desenvolvimento destes relacionamentos. Para o objetivo da investigação são considerados dois quadros conceptuais complementares, focando tanto a interação, como o desenvolvimento dos relacionamentos. É considerada uma estratégia de caso de estudo múltiplo na indústria farmacêutica portuguesa. Foram identificadas onze empresas portuguesas com unidades de produção em Portugal e todas participaram na presente investigação. Nove casos de estudo foram selecionados, considerando o acesso a ambos os lados do relacionamento e a riqueza dos dados recolhidos. Os dados forarn obtidos sobretudo em entrevistas aprofundadas e foram complementados com observação e com dados secundários. Os dados qualitativos foram tratados através de urn processo analítico que envolve compilação, desagregação, remontagem, interpretação e conclusão. A interação entre concorrentes pode ser caracterizada através de quatro dimensões: contexto, natureza, processos de interação e resultados. 0 papel do contexto partilhado, do grau de coopetição (ao·nível da empresa e do departamento), da troca de informação, dos processos de coordenação e dos laços criados está fortemente relacionado com a interação e o desenvolvimento do relacionamento horizontal. 0 desenvolvimento do relacionamento entre concorrentes pode conter cinco fases: co-existência, formação, desenvolvimento, dormência e dissolução. É identificada a presença de um catalisador (e.g. agência governamental) que induz o desenvolvimento do relacionamento entre concorrentes. 0 desenvolvimento de relacionamentos entre concorrentes afeta o poder de negociação, os processos de intemacionalização e o desenvolvimento de relacionamentos público-privados.
Horizontal relationships, such as strategic alliances, are of increasing importance and prevalence. The purpose of this research is to understand horizontal relationships ' development within an interaction and network perspective. Significant research has been carried out on strategic alliances, focusing on motivations, antecedents, formation, and outcomes. However researchers have paid far less attention to the developmental processes of these business relationships. To tackle the research objective two complementary conceptual frameworks are considered, one, addressing the interaction and, another, the relationship development. This research, mainly supported by the industrial marketing and purchasing approach, focuses on: the interaction between competitors, the intercompetitor relationship development and the network effect of such business relationships. It is considered a multiple case study strategy within the Portuguese pharmaceutical industry. Eleven Portuguese pharmaceutical companies with production facilities in-country were identified and all participated in the present research. Nine case studies were purposefully selected, considering the access to both sides of the intercompetitor relationship and the intensive and rich information within. Data was collected mainly through in-depth inteniiews and complemented by observation and secondary data. The qualitative data·· was examined adopting the analytical process of compiling, disassembling, reassembling, interpreting and concluding. Intercompetitor interaction can be characterized along four linked dimensions: context, nature, interaction processes and outcomes. The role of the relationship shared context, coopetition degree (at the company and department levels), informat.ion exchange, coordination processes and bond development is strongly related with the·interaction and the development of the horizontal relationship. The intercompetitor relationship development may comprise five main phases: co-existence, formation, development, dormant and dissolution. The presence of a catalyst (e.g. government body) triggering the intercompetitor relationship development is denoted. The development of relationships between competitors affects the companies' negotiation power, the internationalization processes and the public-private relationships development.

This study aims at introducing and describing a novel multi parameter analysis method to identify potential acquisition targets and to qualitatively and quantitatively evaluate the overall match between a target company and its acquirer. The method was tested with two recent real cases involving each an antibody based biotech company and a large fully integrated pharmaceutical company. The model was validated by comparing two independent antibody companies against the real cases, testing if they would have made better targets. It was found out that the in reality acquired companies scored highest, thus proving the validity of the method. One of the four potential targets got the highest scores for both acquirers. Consequently one of the acquired targets was only the second best match. The still independent companies would not have been better targets. The lowest scoring target company did get identical scores for both acquiring companies. Despite the proper prediction of targets, the scoring did not reveal the true underlying motives for the acquisitions, nor could significant parameters be identified to discriminate between target and non-target. This study adds a novel, valuable tool to the still limited arsenal of methods to qualitatively and quantitatively measure a match between target and acquirer solely based on publicly available data.

Includes list of Supplementary refereed publications relating to thesis; and of Refereed conference papers, as appendix 1 Includes bibliograhical references (p. 316-343) Focusses particularly on the purchase of wine and the factors that influence consumer choice and the values that drive the decision process across different consumption occasions. The effectiveness of occasion as part of the theoretical model of means-end chain analysis is investigated, as well as the feasibility of occasion in the Olsen and Thach (2001) conceptual framework of consumer behavior relating to wine.

Bibliography: leaves 135-143. An anthropological analysis of an industrial dispute that occurred within the East Gippsland forest industry, 1997-1998 and how the workers strove to acheive better working conditions for themselves, and to share in the wealth they had created.

In listening to members of different cultures, it is possible to feel bad, even while recognising that the speaker is trying to speak politely. Sometimes we do not feel very comfortable with someone else’s speech, even though their expressions might be very polite with the choice of specific linguistic forms to show a high level of formality such as terms of address and specific types of formulaic expression such as ' I (don 't) think ... ' or ' I (don't) believe' . The speaker may be intending to speak politely in a considerate way. But the hearer's reaction may be quite different.

The use of indigenous knowledge (IK) and indigenous bio-resources by pharmaceutical and herbal industries has led to concerns about the need to protect IK in order to prevent biopiracy and the misappropriation of indigenous knowledge and resources. While some commentators believe that intellectual property rights (IPR) law can effectively protect IK, others are more sceptical. In order to contribute to the growing debate on this issue, this study uses the relatively new and as yet largely critically unanalysed Masakhane Pelargonium case to address the question of whether or not IPR law can be used to effectively protect IK. It is argued here that discussion about the protection of IK is a matter that must be located within broader discussions about North-South relations and the continued struggle for economic and political freedom by indigenous people and their states. The Masakhane case suggests that IPR law in its current form cannot provide sufficient protection of IK on its own. Incompatibilities between IPR law and IK necessitate that certain factors, most important of which are land, organised representation, and what are referred as 'confidence and network resources', be present in order for IPR law to be used with any degree of success. The study also reveals various factors that undermine the possibility of using IPR law to protect IK. In particular, the study highlights the way in which local political tensions can undermine the ability of communities to effectively use IPR law to protect their knowledge. The thesis concludes with several recommendations that will enable indigenous communities and their states to benefit more substantially from the commercialisation of their bio-resources and associated IK.

by Ma Pui Yin, Flora.
Thesis (M.B.A.)--Chinese University of Hong Kong, 1993.
Includes bibliographical references (leaf 62).
Chapter I. --- INTRODUCTION
The Company Background --- p.1
The Appeal of PRC --- p.3
Scope and Objectives --- p.5
Structure of the Paper --- p.5
Chapter II. --- METHODOLOGY
Michael Porter's Model --- p.7
Evaluation of Porter's Model --- p.8
Lessons from Case Studies --- p.14
Chapter III. --- INDUSTRY ANALYSIS
Intensity of Rivalry Among Existing Competitors --- p.15
Threat of New Entrants --- p.21
Threat of Substitutes --- p.32
Bargaining Power of Buyers --- p.33
Bargaining Power of Suppliers --- p.35
Summary --- p.35
Chapter IV. --- COMPETITIVE STRATEGY
Entry Strategy --- p.38
Portfolio Strategy --- p.41
Targeting Strategy --- p.44
Alliance Strategy --- p.46
Chapter V. --- CONCLUSION --- p.49
APPENDIX --- p.53
REFERENCES --- p.62

This thesis examines the use of new technology in the post-war Australian poultry and pig industries and the implications of this technology for animal welfare. The literature on animal welfare and technology adoption has been brought together using an organisations perspective. It is argued that in order to understand why new technology has been adopted it is necessary to examine the organisations and institutions which influence farmer decision-making. Farmers are constrained to varying degrees by the organisations and institutions in their operational environment and as they have adopted increasingly sophisticated technology developed off the farm they have lost further control over decision-making. The theoretical framework emphasises the interaction between farmers and organisations but also takes account of the wider political economy and the role of individuals. The separate chapters discuss the changes that have occurred in the layer, broiler and pig industries. The use of intensive technology has increased efficiency and reduced uncertainty in the production process. Balanced against these advantages are welfare disadvantages. Intensive technology has been criticised by welfare groups who have put new pressures on farmers. As a result farmers have been placed in a difficult situation: to remain economically viable they have been forced to adopt new technology yet at the same time they have been criticised for using it. Analysis focuses on the differing perspectives taken by the major groups in the welfare debate in order to clarify their positions. The determination of welfare is discussed with reference to the problems involved in assessing optimum or even acceptable conditions. There are a number of areas in which welfare and farm profits can be improved together, and others where increased animal welfare will incur higher costs. These will have to be met by the consumer, either directly through higher prices or indirectly through subsidies to the industries.

The study aims to explore the critical issues facing practitioners in post-merger integration (PMI) involving Western and Chinese pharmaceutical companies and to address the strategic management aspects that should be addressed to ensure merger success and synergy realization. By drawing on specific issues, actions/solutions, and outcomes in the post-merger integration of operational/ functional areas, new understanding on strategic management decisions and actions in pre-deal diligence and post-merger integrating process can be generated to explain merger success or failure. The objective of this research is, therefore, to provide more in-depth and substantive propositions to practitioners in Chinese pharmaceutical mergers and acquisitions to achieve successful post-merger integration.
The study has demonstrated the application of the integrative model, based on the mergers and acquisitions (M&A) integration framework of Larsson and Finkelstein (1999) and other theorists on the Chinese context, to various degrees of success. It has been shown that there are problems involved with applying Western integration models to Chinese companies, due to some Chinese management practices and the influence of the state during the state-owned-enterprise-reform process. As shown by the case studies of this research, the post-merger integration process and merger success in terms of synergy realization and shareholder value creation are closely related. Chinese company leadership with more M&A expertise from prior learning experience, as well as its good relationship (guanxi) with the state, is of great importance in securing good M&A deals and positive outcomes from integration with the former state-owned enterprises (SOEs).
It is hoped that the study has provided a framework for understanding why certain mergers and acquisitions fail in China and how that can be improved. In essence, this research has made a contribution to knowledge about the theory and practice of M&A in the China context as its findings were based on the input of ten top pharmaceutical executives and their senior staff. Due to the sharp increase in mergers and acquisitions in China, the study will help to shed light for future studies that will benefit academics and practitioners alike. Moreover, the study has also demonstrated good opportunities for conducting case study research through interviews in Chinese companies today.
Thesis (DBA(DoctorateofBusinessAdministration))--University of South Australia, 2005

碩士
國立中興大學
科技管理研究所
102
In this study, we studied two case of creative quarters. One is the Kelvin Grove in Queensland, Australia. Other one is Granville Island District in Vancouver, Canada. Both of them are very famous and successful creative quarters of the world. In this paper, it will be focus on why they are so successful by using University-Industry-Government collaboration models. Finally, the study found that the two creative quarters which operating in University-Industry-Government collaboration models could help them to make their management and development become faster and better.

Includes list of Supplementary refereed publications relating to thesis; and of Refereed conference papers, as appendix 1
Includes bibliograhical references (p. 316-343)
xix, 381 p. : ill. ; 30 cm.
Focusses particularly on the purchase of wine and the factors that influence consumer choice and the values that drive the decision process across different consumption occasions. The effectiveness of occasion as part of the theoretical model of means-end chain analysis is investigated, as well as the feasibility of occasion in the Olsen and Thach (2001) conceptual framework of consumer behavior relating to wine.
Thesis (Ph.D.) -- University of Adelaide, School of Agriculture and Wine, Discipline of Wine and Horticulture, 2003

劉鵬.
Thesis (doctoral)--Chinese University of Hong Kong, 2008.
Includes bibliographical references (p. 450-498).
Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web.
Abstracts in Chinese and English.
Liu Peng.

The National Museum of Australia (NMA) (1997- 2001) by architects Ashton Raggatt McDougall (ARM) in association with Robert Peck von Hartel Trethowan was commissioned by the Australian Commonwealth Government for the Centenary of Federation in 2001. It was conceived as a gift to the people of Australia and now stands on Acton Peninsula in Canberra, the nation's Capital. It is a visually complex manifestation of the design architects' (ARM) dialogue with the ambiguities of Australian history and national identity. The architectural realisation of these complexities was facilitated through advances in computer technologies and a complementary non-traditional procurement method, both at the leading edge of Australian architectural practice of the time. Completed three years earlier was probably the most debated work of architecture of the 1990s, the Guggenheim Museum (GMB) (1991-98) in Bilbao, Spain, by Frank O. Gehry and Associates (FOG&A). This satellite museum of the Guggenheim Foundation of New York was heralded as the quintessential example of a kind of architecture only possible because of advances in computer technologies. Both visually complex museums were conceived as flagship projects and consequently share many political, functional, and cultural expectations. Both were procured outside the usual adversarial designer/builder paradigm of western architecture and featured the innovative use of three-dimensional (CAD) software for design, documentation and analysis. The NMA project used a government instigated procurement method which was embraced by a group of design and construction companies who formed a joint venture known as the Acton Peninsula Alliance. This non-traditional or relationship-based procurement method required ARM to reassess their approach to generate and disseminate design data and their traditional relationship with other design and construction professionals. As part of this process, ARM were required to devolve some of their design authority to a project delivery team via a Design Integrity Panel and an Independent Quality Panel; both innovations integral to the Acton Peninsula Alliance. The NMA project reframed many of the enduring professional relationships of Australian architecture and in so doing extended the skill set and expectations of the architects and others to include a more substantial engagement with 3D CAD and a procurement system which was less subject to many of the common impediments inherent in the more traditional processes. Through a series of interviews with the architects and other stakeholders, a qualitative methodology was used to investigate the NMA as a case study which uses the GMB as an internationally recognised comparison. This thesis examines how these two projects have been successfully completed within time and budgetary constraints in an environment where flagship projects have had a history of highly publicised difficulties. It reveals that the successful realisation of the NMA was due to the relationships built or reframed as a result of this cooperative approach in conjunction with high levels of engagement with computer technologies. This is in contrast to the seamless flow of data and high levels of prefabrication integral to the success of the GMB.
http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1255317
Thesis (Ph.D.) -- University of Adelaide, School of Architecture, Landscape Architecture and Urban Design, 2006.

The National Museum of Australia (NMA) (1997- 2001) by architects Ashton Raggatt McDougall (ARM) in association with Robert Peck von Hartel Trethowan was commissioned by the Australian Commonwealth Government for the Centenary of Federation in 2001. It was conceived as a gift to the people of Australia and now stands on Acton Peninsula in Canberra, the nation's Capital. It is a visually complex manifestation of the design architects' (ARM) dialogue with the ambiguities of Australian history and national identity. The architectural realisation of these complexities was facilitated through advances in computer technologies and a complementary non-traditional procurement method, both at the leading edge of Australian architectural practice of the time. Completed three years earlier was probably the most debated work of architecture of the 1990s, the Guggenheim Museum (GMB) (1991-98) in Bilbao, Spain, by Frank O. Gehry and Associates (FOG&A). This satellite museum of the Guggenheim Foundation of New York was heralded as the quintessential example of a kind of architecture only possible because of advances in computer technologies. Both visually complex museums were conceived as flagship projects and consequently share many political, functional, and cultural expectations. Both were procured outside the usual adversarial designer/builder paradigm of western architecture and featured the innovative use of three-dimensional (CAD) software for design, documentation and analysis. The NMA project used a government instigated procurement method which was embraced by a group of design and construction companies who formed a joint venture known as the Acton Peninsula Alliance. This non-traditional or relationship-based procurement method required ARM to reassess their approach to generate and disseminate design data and their traditional relationship with other design and construction professionals. As part of this process, ARM were required to devolve some of their design authority to a project delivery team via a Design Integrity Panel and an Independent Quality Panel; both innovations integral to the Acton Peninsula Alliance. The NMA project reframed many of the enduring professional relationships of Australian architecture and in so doing extended the skill set and expectations of the architects and others to include a more substantial engagement with 3D CAD and a procurement system which was less subject to many of the common impediments inherent in the more traditional processes. Through a series of interviews with the architects and other stakeholders, a qualitative methodology was used to investigate the NMA as a case study which uses the GMB as an internationally recognised comparison. This thesis examines how these two projects have been successfully completed within time and budgetary constraints in an environment where flagship projects have had a history of highly publicised difficulties. It reveals that the successful realisation of the NMA was due to the relationships built or reframed as a result of this cooperative approach in conjunction with high levels of engagement with computer technologies. This is in contrast to the seamless flow of data and high levels of prefabrication integral to the success of the GMB.
Thesis (Ph.D.) -- University of Adelaide, School of Architecture, Landscape Architecture and Urban Design, 2006.

Research into customer service in the manufacturing industry has lagged behind that in service industries, where superior service quality is the most important strategic priority and companies that focus on their customers will build a loyalty that will preclude competitors. In the service industry, customer service needs to be designed for the particular product and process, with measurable outcomes that deliver the results of consumer research. In the manufacture of consumer goods, the product needs to be augmented by customer service factors which fall into the areas of design activities to enhance physical quality, as well as non physical or service activities such as response times, delivery, installation and after-sales repairs. However it is dangerous for a company to try to compete by offering superior service on all dimensions simultaneously and trade offs must be made based on appropriate consumer research. The overall objective of this research was to provide strategic direction for improving quality and customer service in the paper converting industry. The research achieved that aim by determining the requirements of quality and service for different customers, different products and market segments, through a newly extended process which obtained feedback from corporate customers and two groups of end users, those purchasing premium products and those purchasing low cost products. In the business being considered, surveys had already been conducted by semantic network analysis and gap analysis by market research consultants. This research carried out additional surveys and compared them with those already available. The present research employed a cross-sectional causal field experiment using two questionnaires. Because responses were obtained from both national intermediary and representative napkin end users, each survey had a common core, applicable to all respondents and individual sections for corporate customer and end users. As a result of the surveys, it was concluded that considerable differences existed between intermediary users and end users in: - their ranking of elements of quality and customer service, - their ranking of the technical aspects of quality and, - their evaluation of the suitability of a napkin for their use. A series of specific differences were found, of which the most important are: - all the customers expect quality and there are no significant differences in their views, but low series napkin users have lower quality expectations. - premium product users require a wider range of napkins than corporate users, who have their own specific narrow range, and low cost users who expected a limited choice. - corporate customers want better stock availability and full quantity deliveries at the exact time and day specified. It was concluded that the detailed surveys, in the present research, had greater validity than previous ones because they covered a wider range of customer requirements, not limited to those already being offered. The research made a series of recommendations about, for example, softness and embossing standards in manufacturing, which it is hoped will be adopted. The aim, to obtain feedback across the whole range of customer requirements for future strategic direction, had been achieved.

This thesis investigates the implications of implementing TRIPS in India for access to medicines drawing on three major factors: (i) the TRIPS agreement, (ii) the global pharmaceutical industry and (iii) the development of Indian pharmaceutical industry and the level of access to medicines in India. In doing so, the thesis examines the requirements of the TRIPS agreement and analyses the costs and benefits of its implementation, especially from a developing country view point. The fairness test shows that TRIPS prematurely forces developing countries to adopt protection standards, which a number of developed countries themselves did not adopt until they had achieved a certain level of economic development